foxo4-dri senescence regulates endothelial cell via the P53 signaling pathway FOXO4-DRI
FOXO4 DRI FOXO4 DRI 99% Purity, COA Included Glow Peptides FOXO4 10mg Vial Buy Online Crystal Peptides FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





